Floatz logo

FAPi-46

Idiopathic Interstitial Pneumonias

University of California, Los AngelesSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Idiopathic Interstitial Pneumonias cohort.

Asset / SponsorPhaseRating
BARDOXOLONE METHYL ESTER
Biogen
Phase 2B
5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-
Celgene
Phase 2CCC

Same molecule, other indications

FAPi-46 is also rated in:

cholangiocarcinomaDormant
CCC
Indicative ·
55 / 100
View asset →
melanomaDormant
CCC
Indicative ·
53 / 100
View asset →
amyloidosisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →